Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-05-20

Clinical Trial Update: The INVADER™ Percutaneous Transluminal Coronary Angioplasty (PTCA) Post Market Clinical Follow-up (PMCF) Study

View source ↗

Summary

The INVADER PMCF post-market study for the INVADER PTCA device has completed follow-up, with data collection in patients with coronary artery disease and relate…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • INVADER PTCA

Snippet

Sponsor: Alvimedica | Conditions: Coronary Artery Disease, Coronary Disease | Status: COMPLETED